Cardiotrophin-1 attenuates endotoxin-induced acute lung injury.
暂无分享,去创建一个
R. McIntyre | B. Cain | B. Shames | D. Pennica | D. Bensard | E. J. Pulido | R. O'Leary
[1] N. Maekawa,et al. Aminoguanidine attenuates endotoxin-induced acute lung injury in rabbits. , 1998, Critical care medicine.
[2] M. Sagy,et al. A comparison among animal models of acute lung injury. , 1998, Critical care medicine.
[3] A. Stephanou,et al. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. , 1998, Journal of molecular and cellular cardiology.
[4] Y. Nagashima,et al. Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. , 1998, Journal of immunology.
[5] E. Deitch. ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED , 1998, Shock.
[6] N. Tamura,et al. Endothelin-1 and cardiotrophin-1 induce brain natriuretic peptide gene expression by distinct transcriptional mechanisms. , 1998, Journal of cardiovascular pharmacology.
[7] T. Hirano,et al. Signaling mechanisms through gp130: a model of the cytokine system. , 1997, Cytokine & growth factor reviews.
[8] H. Wong,et al. The stress response and the lung. , 1997, The American journal of physiology.
[9] K. Chien,et al. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development , 1997, Journal of Molecular Medicine.
[10] S. Chevalier,et al. Signaling of the Cardiotrophin-1 Receptor , 1997, The Journal of Biological Chemistry.
[11] R. McIntyre,et al. Endotoxin differentially impairs cyclic guanosine monophosphate-mediated relaxation in the pulmonary and systemic circulations. , 1997, Critical care medicine.
[12] P. Ghezzi,et al. Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice and in vitro in mouse blood cells. , 1996, The American journal of pathology.
[13] Arthur S Slutsky,et al. Effects of the stress response in septic rats and LPS-stimulated alveolar macrophages: evidence for TNF-alpha posttranslational regulation. , 1996, American journal of respiratory and critical care medicine.
[14] R. McIntyre,et al. Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation. , 1996, The American journal of physiology.
[15] A. Dorner,et al. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. , 1996, Journal of immunology.
[16] S. Rockwell,et al. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. , 1996, Journal of immunology.
[17] M. Cairo,et al. Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats. , 1996, Blood cells, molecules & diseases.
[18] B. Barton,et al. Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model , 1996, Infection and immunity.
[19] G. Fantuzzi,et al. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. , 1996, Blood.
[20] K. Nakao,et al. cDNA cloning of rat cardiotrophin-1 (CT-1): augmented expression of CT-1 gene in ventricle of genetically hypertensive rats. , 1996, Biochemical and biophysical research communications.
[21] W. Zapol,et al. In vivo lipopolysaccharide pretreatment inhibits cGMP release from the isolated-perfused rat lung. , 1995, The American journal of physiology.
[22] P. Ghezzi,et al. Ciliary Neurotrophic Factor Inhibits Brain and Peripheral Tumor Necrosis Factor Production and, When Coadministered with Its Soluble Receptor, Protects Mice From Lipopolysaccharide Toxicity , 1995, Molecular Medicine.
[23] L. Carey,et al. Endotoxin infusion in anesthetized sheep is associated with intrapulmonary sequestration of leukocytes that immunohistochemically express tumor necrosis factor‐α , 1995, Journal of leukocyte biology.
[24] R. McIntyre,et al. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. , 1995, The American journal of physiology.
[25] W. Wood,et al. Cardiotrophin-1 , 1995, The Journal of Biological Chemistry.
[26] P. Waring,et al. Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] K. Chien,et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Williams,et al. Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. , 1994, The American journal of physiology.
[29] A S Slutsky,et al. Induction of the heat shock response reduces mortality rate and organ damage in a sepsis‐induced acute lung injury model , 1994, Critical care medicine.
[30] Z. Ba,et al. Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. , 1994, The American journal of physiology.
[31] S. Akira,et al. Cytokine signal transduction , 1994, Cell.
[32] K. Albertine,et al. Loss of endothelium-dependent vasodilation in the pulmonary vessels of sheep after prolonged endotoxin. , 1994, Journal of applied physiology.
[33] M. Jordana,et al. Polymorphonuclear leukocytes as a significant source of tumor necrosis factor-alpha in endotoxin-challenged lung tissue. , 1993, The American journal of pathology.
[34] Daniel,et al. Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. , 1993, The Journal of clinical investigation.
[35] S. Peters,et al. A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. , 1992, The American review of respiratory disease.
[36] J. Norton,et al. Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor , 1992, The Journal of experimental medicine.
[37] B. Meyrick,et al. Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor alpha. , 1991, The American review of respiratory disease.
[38] J. Vilček,et al. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. , 1989, Journal of immunology.
[39] T. Raffin,et al. Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. , 1988, The American review of respiratory disease.
[40] N. Voelkel,et al. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. , 1987, The Journal of clinical investigation.
[41] J. Repine,et al. Neutrophils and Adult Respiratory Distress Syndrome , 1983, The Lancet.
[42] B. Meyrick,et al. Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep structure:function relationships. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[43] F. Lewis,et al. Cardiopulmonary parameters and prognosis after severe multiple trauma. , 1979, The Journal of trauma.
[44] W. Zapol,et al. Pulmonary hypertension in severe acute respiratory failure. , 1977, The New England journal of medicine.
[45] K. Brigham,et al. Effect of Increased Vascular Pressure on Lung Fluid Balance in Unanesthetized Sheep , 1975, Circulation research.